Delivery Order SPE2DR25D3103-SPE2DR26F0B5V

<p>The Defense Logistics Agency issued a $3,486.67 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Benlysta 200 mg/ml autoinjector with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for Benlysta 200 mg/ml auto-injector with a ceiling value of $3,486.67 and an ultimate completion date of February 26, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $6,973.34 for Benlysta 200 mg/ml auto-injector supply.</p> <p>Place of performance is Conshohocken, PA. The order is due February 27, 2026, and priced on a firm fixed-price basis with no set-aside.</p>

The Defense Logistics Agency awarded a $6,973.34 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 29, 2026, for the supply of Benlysta 200 mg/ml auto-injector, with performance completion scheduled for February 20, 2026. This non-competitive delivery order was issued to the Conshohocken, Pennsylvania-based pharmaceutical distributor as a child entity under its parent company, Cencora, Inc. (formerly Amerisourcebergen). The delivery will be performed at the contractor's...

The Defense Logistics Agency awarded a $6,165.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product, with performance in Conshohocken, Pennsylvania. The contract, awarded on October 22, 2025, carries an ultimate completion date of November 13, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...

The Defense Logistics Agency awarded a delivery order valued at $3,486.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors, with a completion deadline of January 26, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on January 2, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...

The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 18, 2025, with completion scheduled by December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a prescription biologic medication used primarily in the treatment of systemic lupus erythematosus,...

The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with DLA to supply...

On February 4, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,460.01 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 26, 2026 and carries no set-aside designation, indicating full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...

The Defense Logistics Agency awarded a $13,946.68 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on February 4, 2026, for Benlysta 200 mg/mL auto-injector pharmaceutical supply. This is a firm fixed-price delivery order with no set-aside designation, utilizing a competitive procurement process. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 26, 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical...